Ovulation Testing Kits Market Report 2025

This Ovulation Testing Kits market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The ovulation testing kits market size has grown rapidly in recent years. It will grow from $3.02 billion in 2024 to $3.34 billion in 2025 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to increased fertility awareness, rising trend of family planning, growing emphasis on women's health, expanding the availability of over-the-counter options, and growing demand for accurate ovulation testing kits.

The ovulation testing kits market size is expected to see rapid growth in the next few years. It will grow to $4.95 billion in 2029 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to the expanding global population and increasing birth rates, rising prevalence of fertility issues and delayed childbearing, growing adoption of digital health solutions and mobile apps, increasing awareness and acceptance of at-home fertility testing, and expanding access to healthcare in emerging markets. Major trends in the forecast period include personalized fertility tracking solutions, integration of artificial intelligence in ovulation prediction, the emergence of wearable fertility trackers, eco-friendly and sustainable ovulation testing options, and telemedicine and remote monitoring for fertility management.

The decline in fertility rates is expected to drive the growth of the ovulation testing kits market. Fertility rates refer to the number of live births within a population over a specific period, typically expressed as the number of births per 1,000 women of childbearing age (usually aged 15-49) in a year. The decrease in fertility rates is influenced by factors such as greater education and career opportunities for women, better access to and use of contraceptives, delayed marriage and childbearing, and high living costs. Ovulation testing kits are valuable tools for individuals or couples experiencing low fertility rates, offering a non-invasive and accessible way to optimize the timing of intercourse and increase the chances of conception. For example, according to the Office for National Statistics, a UK-based governmental organization, the total fertility rate (TFR) in England and Wales decreased from 1.49 children per woman in 2022 to 1.44 in 2023, the lowest rate on record. As a result, declining fertility rates are contributing to the growth of the ovulation testing kits market.

Major players in the ovulation testing kits market are concentrating on forging strategic alliances to gain a competitive advantage. These strategic alliances involve collaborative endeavors among key industry stakeholders aimed at bolstering market presence, broadening product portfolios, and leveraging emerging prospects. They encompass partnerships, joint ventures, collaborations, and agreements among manufacturers, distributors, healthcare providers, and other relevant entities to achieve shared goals and foster market expansion. For example, in November 2022, Innova Medical Group, a US-based healthcare entity specializing in COVID-19 antigen tests, teamed up with iXensor, a Taiwan-based company offering a mobile health diagnosis platform, to introduce the 'PHRONESIA Smart Ovulation Test,' an intelligent ovulation testing solution. This test integrates PixoTech technology and leverages iXensor's expertise. PixoTech technology holds promise in meeting the escalating demand for intelligent at-home testing through collaborations with lateral flow assay manufacturers, pharmaceutical firms, and MedTech innovators.

In December 2023, Biogenes Technologies Sdn Bhd, a Malaysia-based biotechnology company, acquired Allen Healthcare Products for an undisclosed sum. This strategic acquisition is intended to boost Biogenes Technologies' production capacity for diagnostic test kits, enhance its research capabilities, and expand its footprint in the Southeast Asian market. Allen Healthcare Products, also based in Malaysia, specializes in rapid test kits, including ovulation test kits.

Major companies operating in the ovulation testing kits market are Church & Dwight Co Inc, Piramal Enterprises Inc., Meril Diagnostics Pvt Ltd, Roman Health Ventures Inc, BIOSYNEX SA, Boditech Med Inc., Mankind Pharma Ltd., Innovita Biological Technology Co., Ltd., Hangzhou Clongene Biotech Co., Ltd., Swiss Precision Diagnostics GmbH, Artron Laboratories Inc., Wondfo Biotech Co., Ltd., AdvaCare Pharma, Proov, Shanghai Chemtron Biotech Co., Ltd., Apollo Pharmacy Pvt. Ltd., Ava Science Inc., Clinical Guard Ltd., Fairhaven Health LLC, Femometer Ltd., iProven, Megna Health Inc., Easy Healthcare Corporation (Premom), Biotrol Laboratories Private Limited, Tulip Diagnostics Pvt. Ltd.

North America was the largest region in the ovulation testing kits market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ovulation testing kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the ovulation testing kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Ovulation testing kits are diagnostic devices crafted to assist individuals in pinpointing the most fertile days of their menstrual cycle by detecting the surge in luteinizing hormone (LH) that occurs before ovulation. These kits are frequently employed by couples seeking to conceive to determine the best timing for intercourse, thereby enhancing the chances of pregnancy. Serving as valuable aids in family planning, these kits provide a non-intrusive and simple means to comprehend and leverage the body's natural fertility cues.

The primary categories of ovulation testing kits include urine-based, saliva-based, and salivary ferning kits. Urine-based kits utilize hormonal changes in urine to forecast ovulation. They are available through various distribution channels such as pharmacies, drugstores, hypermarkets, supermarkets, e-commerce platforms, and others. These kits cater to diverse end users including hospitals, clinics, diagnostic centers, fertility centers, home care settings, and others.

The ovulation testing kits market research report is one of a series of new reports that provides ovulation testing kits market statistics, including the ovulation testing kits industry global market size, regional shares, competitors with ovulation testing kits market share, detailed ovulation testing kits market segments, market trends, and opportunities, and any further data you may need to thrive in the ovulation testing kits industry. This ovulation testing kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The ovulation testing kits market consists of sales of digital ovulation predictor kits, combination kits, fertility monitors, and ovulation prediction wearables. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.